Login
$CL
$100.99 +$0.00 (0.0%) After hours

$CL 8-K SEC Filings

Filed On Filing
30 Oct 2026 8-K: Results of Operations and Financial Condition

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - No...

31 Jul 2026 8-K: Results of Operations and Financial Condition

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - No...

13 May 2026 8-K: Submission of Matters to a Vote of Security Holders

(a) The Company’s Annual Meeting of Stockholders was held on May 8, 2026. The matters voted on and the results of the vote were as follows.

01 May 2026 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” and “Table 6 - No...

09 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

Jennifer M. Daniels, who has served as Chief Legal Officer and Secretary of Colgate-Palmolive Company (the “Company”) since 2014, has communicated to the Company her intention to retire from the Company in 2026. As a result, on April 8, ...

17 Mar 2026 8-K: Other Events

(1) Net sales in the United States for Oral, Personal and Home Care were $3,596 in 2025.

12 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

On March 12, 2026, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate-Palmolive”) elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (“Bristol Myers Squ...

30 Jan 2026 8-K: Results of Operations and Financial Condition

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 7 - Geographic Sales Analysis Percentage Changes” and “Table 9 - No...

10 Nov 2025 8-K: Other Events

Colgate-Palmolive Company, a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the pri...

31 Oct 2025 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - No...

01 Aug 2025 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - No...

29 May 2025 8-K: Departure/Election of Directors or Officers; Compensation

On May 29, 2025, Colgate-Palmolive Company (the “Company”) announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executi...

14 May 2025 8-K: Submission of Matters to a Vote of Security Holders

(a) The Company’s Annual Meeting of Stockholders was held on May 9, 2025. The matters voted on and the results of the vote were as follows.

02 May 2025 8-K: Other Events

Colgate-Palmolive Company, a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the pri...

25 Apr 2025 8-K: Results of Operations and Financial Condition

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” and “Table 6 - No...

31 Jan 2025 8-K: Results of Operations and Financial Condition

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 7 - Geographic Sales Analysis Percentage Changes” and “Table 9 - No...

25 Oct 2024 8-K: Other Events

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - No...

26 Jul 2024 8-K: Results of Operations and Financial Condition

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - No...

15 May 2024 8-K: Submission of Matters to a Vote of Security Holders

(a) The Company’s Annual Meeting of Stockholders was held on May 10, 2024. The matters voted on and the results of the vote were as follows.

26 Apr 2024 8-K: Results of Operations and Financial Condition

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 5 - Geographic Sales Analysis Percentage Changes” and “Table 6 - No...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support